For the purpose of supporting its financing activities, a leading automotive consumer products company engaged CRA to appraise its core trademark and related intangible assets in the United States, as well as subsidiary trade names in Europe. In addition, CRA provided a valuation analysis of the company’s trademark royalty revenues from licensees in non-core geographical territories.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...